Back
Fidelity National Information Services Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
50
FIS
Fidelity National Information Services
Last Price:
74.64
Seasonality Move:
-2.02%
Buy
75
MIRM
Mirum Pharmaceuticals
Last Price:
32.98
Seasonality Move:
6.63%
Sell
50
Fidelity National Information Services (FIS)
is a Sell
Is Fidelity National Information Services a Buy, Sell or Hold?
- The current Fidelity National Information Services [FIS] share price is $75.20. The Score for FIS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- FIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $33.15. The Score for MIRM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FIS Stock Price Chart
What is Fidelity National Information Services's stock price today?
-
The Fidelity National Information Services share price today is $75.20
The current trend is moderately bearish and FIS is experiencing selling pressure, which indicates risk of future bearish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $33.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing selling pressure, which indicates risk of future bearish movement.
FIS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.32 | Buy |
Relative Strength Index (14 RSI): | 46.81 | Sell |
Chaikin Money Flow: | -2242799 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (75.36 - 77.34) | Sell |
Bollinger Bands (100): | (66.39 - 75.95) | Buy |
MIRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.01 | Buy |
Relative Strength Index (14 RSI): | 64.44 | Buy |
Chaikin Money Flow: | -648557 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.98 - 30.18) | Buy |
Bollinger Bands (100): | (24.4 - 28.72) | Buy |
FIS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 76.25 | Sell |
20-day SMA: | 76.08 | Sell |
50-day SMA: | 74.26 | Buy |
200-day SMA: | 63.83 | Buy |
8-day EMA: | 76.02 | Sell |
20-day EMA: | 76.03 | Sell |
50-day EMA: | 74.47 | Buy |
200-day EMA: | 67.6 | Buy |
MIRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.76 | Buy |
20-day SMA: | 27.49 | Buy |
50-day SMA: | 25.93 | Buy |
200-day SMA: | 28.17 | Buy |
8-day EMA: | 31.17 | Buy |
20-day EMA: | 28.66 | Buy |
50-day EMA: | 27.01 | Buy |
200-day EMA: | 27 | Buy |
Fidelity National Information Services Earnings Growth & FIS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.08 per share, an increase this year of $1.62 per share, and an increase next year of $0.54 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.34 per share, an increase this year of $1.92 per share, and an increase next year of $1.37 per share.
Fidelity National Information Services Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Mirum Pharmaceuticals Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |